Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 9/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 8/20 | 0.52 |
| ▸ | F10 | P00742 | 2/20 | 0.42 |
| ▸ | KDM1A | O60341 | 4/20 | 0.42 |
| ▸ | BRD4 | O60885 | 1/20 | 0.41 |
| ▸ | ALOX5AP | P20292 | 2/20 | 0.41 |
| ▸ | FEN1 | P39748 | 2/20 | 0.41 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8629007 | 0.89 | PTGS2 (0.55) | PTGS2PTGS1F10KDM1ABRD4 | |
| SCHEMBL7780849 | 0.89 | PTGS2 (0.60) | PTGS2PTGS1 | |
| SCHEMBL8631512 | 0.87 | LMNA (0.46) | PTGS2F10ALOX5APFEN1KMT2A | |
| SCHEMBL8635059 | 0.86 | PTGS2 (0.58) | PTGS2PTGS1F10BRD4ALOX5AP | |
| SCHEMBL8627979 | 0.86 | PTGS2 (0.51) | PTGS2PTGS1F10KDM1ABRD4 | |
| SCHEMBL8632643 | 0.86 | PTGS2 (0.53) | PTGS2PTGS1F10KDM1ABRD4 | |
| SCHEMBL8634386 | 0.85 | PTGS2 (0.50) | PTGS2PTGS1F10KDM1ABRD4 | |
| SCHEMBL8627595 | 0.84 | F10 (0.48) | PTGS2F10SCN9AKMT2A | |
| SCHEMBL7779420 | 0.83 | PTGS2 (0.57) | PTGS2PTGS1KDM1A | |
| SCHEMBL8630401 | 0.83 | PTGS2 (0.47) | PTGS2PTGS1F10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5756530-A | NON-STEROIDAL ANTIINFLAMMATORY AGENTS WITH REDUCED SIDE EFFECTS | G. D. SEARLE & CO. (US) | 1998-05-26 | — | — | US | disclosed |